S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
New York lawmakers pass $237 billion budget with policies to jump-start housing market

Homology Medicines (FIXX) Earnings Date, Estimates & Call Transcripts

Skip Charts & View Estimated and Actual Earnings Data

FIXX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

FIXX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Homology Medicines Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.75) EPS
Next Year EPS Consensus Estimate: ($0.70) EPS

FIXX Earnings Date and Information

Homology Medicines has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.

Homology Medicines Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/9/2024
Estimated)
------- 
11/14/2023Q3 2023($0.21)($0.2850)($0.0750)($0.57)--
8/14/2023Q2 2023($0.2550)($0.3050)($0.05)($0.61)-$0.35 million
5/11/2023Q1 2023($0.2750)($0.25)+$0.0250($0.50)$1.35 million$0.80 million
3/9/2023Q4 2022($0.2550)($0.30)($0.0450)($0.60)$1.05 million$0.80 million
11/10/2022Q3 2022($0.2350)($0.2950)($0.06)($0.59)$1.05 million$0.80 million
8/15/2022Q2 2022($0.2850)($0.2550)+$0.03($0.51)$1.05 million$0.80 million
5/16/2022Q1 2022($0.1250)($0.10)+$0.0250($1.99)$1.30 million$0.80 million
3/23/2022Q4 2021($0.29)($0.2950)($0.0050)($0.59)$1.00 million$0.80 million
11/15/2021Q3 2021($0.30)($0.27)+$0.03($0.54)$0.63 million$1.68 million
8/12/2021Q2 2021($0.29)($0.27)+$0.02($0.54)$0.63 million$2.19 million
5/6/2021Q1 2021($0.3050)($0.01)+$0.2950($0.02)$0.78 million$29.31 million  

Homology Medicines Earnings - Frequently Asked Questions

When is Homology Medicines's earnings date?

Homology Medicines has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on FIXX's earnings history.

How much revenue does Homology Medicines generate each year?

Homology Medicines (NASDAQ:FIXX) has a recorded annual revenue of $1.16 million.

How much profit does Homology Medicines generate each year?

Homology Medicines (NASDAQ:FIXX) has a recorded net income of -$112.96 million. FIXX has generated -$1.96 earnings per share over the last four quarters.

What is Homology Medicines's EPS forecast for next year?

Homology Medicines's earnings are expected to grow from ($0.75) per share to ($0.70) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:FIXX) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners